Logo 13 Oct 2025

New clinical trial reg provides path to commercialization for Chinese biomedical tech

Subscribe to keep reading.

Sign up to stay briefed on what the Chinese government is doing, thinking, and saying.

Try it free

Already a subscriber? Log in.

China's new regulation on trialing biomedical technology – approved by the State Council last month and released in full on Friday – provides a clear path from clinical trials to widespread application for the first time. The reg covers frontier biomedical technologies like:

Cell and gene therapies...



More recent developments

Logo April 22, 2026
Beijing nudges SOEs to adopt agentic AI

What happened: On April 21, the State Council released opinions to promote high-quality development of the services sector. What caught our eye: the document calls for: “Accelerating the development and adoption of smart programming tools and supporting the procurement of… Read More »

Logo April 21, 2026
MSS warns about data poisoning

Model security is national security. What happened: On April 21, the Ministry of State Security (MSS) issued a warning on the growing risks of “data poisoning” as AI tools proliferate across society. Data poisoning is the practice of delivering false… Read More »

Logo April 21, 2026
DeepSeek eyes first external funding round

What happened: On April 17, The Information reported that DeepSeek is seeking outside funding for the first time, aiming to raise at least USD 300 million at a valuation north of USD 10 billion. Some context: DeepSeek has so far… Read More »